Glioma |
U251 and U87MG cells |
Downregulation of CD147 |
[87] |
Non-small cell lung cancer |
A549 cells |
Inhibited the STAT3 and AKT pathways, downregulated the expression of Bcl-2 |
[88] |
Breast cancer |
4 T1 and MDA-MB-231 cells |
Regulated p38 signaling pathways |
[15] |
Hpatocellular cancer |
huh7 and BEL7402 cells |
Induced reactive oxygen species (ROS), downregulation of AKT and RIP1/NF-κB activity |
[24] |
Gastric cancer |
AGS、AZ521 and SCM-1 cells |
Upregulated p38 activities,inhibited ERK1/2 and AKT activities |
[17] |
Glioma |
GBM、U87MG、DK-MG cells |
Inhibited the epidermal growth factor receptor signaling pathway |
[52] |
Melanoma |
A357 cells |
Activated ROS-mediated ER stress and p38 pathways |
[74, 89] |
Non-small cell lung cancer |
A549 and NCI-H1437 cells |
Activated FOXO3a/EGR1/SIRT1 signaling |
[90] |
Gastric carcinoma |
AGS cells |
Regulated p53 and Nrf2 signaling pathways |
[91] |
Thyroid carcinoma |
TT cells |
Through the mitochondrial signaling pathway |
[16] |
Gastric cancer |
NCI-N87 cells |
Inhibition of PI3K/AKT signal pathway |
[40] |
Leukemia |
K562 cells |
Increased the PTEN level and inactivated the PI3K/AKT signaling pathway |
[44] |